The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

FDA representatives have urged Congress to review its request for funding as it embarks on a more modern reassessment of ...

Gain Therapeutics' GT-02287 shows promise in treating Parkinson's disease, with positive results and potential for market ...

New restrictions on cosmetics tested on animals, tougher penalties for negligent drivers, requirements for hospitals to offer drugs to people possibly exposed to HIV. These are among the changes in Wa ...